Stephen D Silberstein Selected Research

Headache Disorders (Headache Syndromes)

10/2022	Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition.
1/2021	The Use of Botulinum Toxin in the Management of Headache Disorders.
1/2021	Correction to: The Use of Botulinum Toxin in the Management of Headache Disorders.
1/2019	Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
1/2018	The Use and Method of Action of Intravenous Lidocaine and Its Metabolite in Headache Disorders.
2/2016	The Use of Botulinum Toxin in the Management of Headache Disorders.
10/2012	Spontaneous trigeminal allodynia in rats: a model of primary headache.
12/2010	Acetate causes alcohol hangover headache in rats.
10/2010	Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
2/2009	Intravenous lidocaine infusion for the treatment of post-acoustic neuroma resection headache: a case report.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen D Silberstein Research Topics

Disease

139	Migraine Disorders (Migraine) 05/2022 - 01/2002
73	Headache (Headaches) 01/2022 - 06/2002
40	Pain (Aches) 01/2022 - 10/2002
16	Headache Disorders (Headache Syndromes) 10/2022 - 06/2002
14	Nausea 01/2022 - 11/2005
10	Epilepsy (Aura) 01/2022 - 11/2003
9	Vomiting 01/2022 - 09/2005
7	Photophobia (Light Sensitivity) 10/2021 - 11/2005
7	Hyperacusis (Phonophobia) 10/2021 - 11/2005
7	Cluster Headache (Cluster Headaches) 10/2020 - 05/2005
4	Hypersensitivity (Allergy) 01/2019 - 12/2010
4	Paresthesia (Dysesthesia) 01/2017 - 01/2002
3	Neurogenic Inflammation 01/2018 - 08/2006
3	Migraine with Aura (Familial Hemiplegic Migraine) 01/2015 - 07/2004
3	Hyperalgesia 10/2012 - 06/2007
3	Primary Headache Disorders 04/2004 - 06/2002
2	Nervous System Diseases (Neurological Disorders) 05/2022 - 03/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
2	Prescription Drug Overuse 09/2020 - 06/2016
2	Chronic Pain 11/2018 - 01/2018
2	Weight Gain 01/2017 - 11/2003
2	Secondary Headache Disorders 01/2017 - 08/2013
2	Inflammation (Inflammations) 03/2016 - 01/2016
2	Fatigue 11/2014 - 02/2007
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2014 - 02/2007
2	Disease Progression 07/2014 - 02/2009
2	Overweight 04/2005 - 11/2003
2	Tension-Type Headache (Tension Headache) 09/2003 - 03/2002
1	Gastroparesis 10/2021

Drug/Important Bio-Agent (IBA)

28	Calcitonin Gene-Related PeptideIBA 05/2022 - 10/2010
24	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 01/2002
23	Pharmaceutical PreparationsIBA 10/2022 - 06/2002
21	Monoclonal AntibodiesIBA 05/2022 - 11/2017
20	Topiramate (Topamax)FDA LinkGeneric 11/2019 - 01/2002
18	Tryptamines (Triptans)IBA 01/2020 - 06/2002
15	fremanezumabIBA 01/2022 - 11/2015
10	preemptIBA 12/2020 - 06/2010
10	Pain-FreeIBA 01/2019 - 10/2002
9	NeuropeptidesIBA 05/2022 - 12/2017
9	Anticonvulsants (Antiepileptic Drugs)IBA 03/2019 - 06/2003
8	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 05/2022 - 12/2010
8	Sumatriptan (Imigran)FDA LinkGeneric 02/2018 - 05/2005
7	Dihydroergotamine (Agit)FDA LinkGeneric 01/2022 - 06/2007
7	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 01/2004
7	salicylhydroxamic acid (SHAM)IBA 07/2019 - 04/2010
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2021 - 05/2006
5	frovatriptan (Allegro)FDA Link 10/2009 - 04/2002
4	Lidocaine (Xylocaine)FDA LinkGeneric 01/2022 - 02/2009
4	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 06/2002
4	erenumabIBA 01/2021 - 11/2018
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2004
4	NeurotoxinsIBA 01/2021 - 07/2003
4	Estrogens (Estrogen)FDA Link 01/2020 - 01/2006
4	TabletsIBA 02/2018 - 02/2004
4	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2015 - 09/2005
3	KetorolacIBA 01/2022 - 01/2015
3	MagnesiumIBA 01/2022 - 10/2007
3	Hormones (Hormone)IBA 01/2021 - 01/2006
3	galcanezumabIBA 12/2019 - 01/2019
3	Valproic Acid (Depakote)FDA LinkGeneric 03/2019 - 10/2012
3	Opioid Analgesics (Opioids)IBA 01/2019 - 03/2016
3	Analgesics (Analgesic Drugs)IBA 01/2019 - 01/2004
3	Propranolol (Inderal)FDA LinkGeneric 01/2017 - 06/2005
3	incobotulinumtoxinA FDA Link 04/2005 - 01/2004
2	Ketamine FDA LinkGeneric 11/2021 - 11/2018
2	Ibuprofen (Motrin)FDA LinkGeneric 10/2021 - 03/2006
2	Substance PIBA 01/2020 - 10/2010
2	Glutamic Acid (Glutamate)FDA Link 01/2020 - 10/2010
2	Lamotrigine (Lamictal)FDA LinkGeneric 03/2019 - 06/2004
2	AntibodiesIBA 01/2019 - 12/2017
2	eptinezumabIBA 01/2019 - 11/2014
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2018 - 12/2017
2	PowdersIBA 02/2018 - 01/2018
2	Anesthetics (Anesthetic Agents)IBA 01/2018 - 03/2013
2	Tramadol (K315)FDA LinkGeneric 01/2015 - 11/2005
2	Serotonin AntagonistsIBA 01/2010 - 09/2008
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2010 - 09/2008
2	Antidepressive Agents (Antidepressants)IBA 01/2010 - 09/2008
2	eletriptan (Relpax)FDA Link 05/2007 - 06/2003
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2007 - 06/2002
2	Caffeine (No Doz)FDA LinkGeneric 03/2006 - 09/2005
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2006 - 09/2005
2	rizatriptan (Maxalt)FDA Link 01/2004 - 10/2002
2	candesartanIBA 01/2004 - 06/2003
1	Amino Acids FDA Link 05/2022
1	atogepantIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	EsketamineIBA 11/2021
1	6-hydroxynorketamineIBA 11/2021
1	Meloxicam (Mobic)FDA LinkGeneric 10/2021
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2021

Therapy/Procedure

55	Therapeutics 01/2022 - 03/2002
8	Aftercare (After-Treatment) 01/2022 - 06/2002
8	Injections 11/2020 - 01/2004
6	Vagus Nerve Stimulation 10/2020 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2022 - 03/2003
2	Contraindications 01/2020 - 01/2010
2	Analgesia 11/2018 - 12/2010
2	Transcranial Magnetic Stimulation 01/2018 - 04/2010
1	Intravenous Infusions 01/2022